Europe's STOXX 600 falls a day after Fed-fuelled rally
For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window
Mercedes drops after guidance cut
ASML slides after MS downgrade
STOXX 600 down 1.4%
Updated at 1600 GMT
By Shubham Batra and Shashwat Chauhan
Sept 20 (Reuters) -European shares slipped on Friday after a rally in the previous session spurred by the U.S. Federal Reserve's outsized interest rate cut, while drugmaker Novo Nordisk slid on disappointing obesity pill data.
The pan-European STOXX 600 index .STOXX closed 1.4% lower, though it recorded a second straight week of gains.
All major European stock markets had steep losses, except Spain .IBEX, which closed 0.2% lower.
Novo Nordisk NOVOb.CO shed 5.4% after results from a Phase 2a trial of the Danish drugmaker's experimental obesity pill monlunabant came in below market expectations.
The broader health care sub sector .SXDP eased 1.9%.
Autos .SXAP led declines among the major STOXX sectors, down 3.6%, hurt by a 6.8% slide in Mercedes-Benz MBGn.DE which cut its full-year profit margin target for the second time in less than two months.
Other industry rivals such as Volkswagen VOWG.DE and France's Forvia FRVIA.PA dropped 3.4% and 8%, respectively.
Tech .SX8P eased 2.7% as shares of Dutch computer chip equipment maker ASML ASML.AS lost 4.2% after Morgan Stanley downgraded its rating on the stock to "equal-weight".
Global equities had rallied sharply on Thursday after the Fed on Wednesday kicked off an anticipated series of interest rate cuts with a larger-than-usual half-percentage-point reduction.
"The market is expecting further reductions of a similar amount before the end of the year, and in the absence of an economic downturn, the scene is set for a positive end to the year," said Richard Hunter, head of markets at interactive investor.
On the data front, British retail sales rose by a stronger-than-expected 1% in August and growth in July was revised up, while euro zone consumer confidence rose by 0.5 points in September from the August number.
German producer prices fell less than expected in August, decreasing by 0.8% on the year versus expectations of a 1% decline.
Among other headline stocks, Germany's DHL DHLn.DE dipped 4.4% following U.S. rival FedEx's FDX.N dismal first-quarter results.
Burberry BRBY.L fell 3.5% as Jefferies cut its rating on the British fashion company to "underperform" from "hold" and lowered the target price to 490p from 800p.
Reporting by Shubham Batra and Shashwat Chauhan in Bengaluru; Editing by Varun H K, Mrigank Dhaniwala and Jane Merriman
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
